Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
Author:
Funder
Natural Science Foundation of Shandong Province
Qufu Normal University
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference164 articles.
1. SARS-CoV-2 Omicron BA. 5: evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern;Aggarwal;EBioMedicine,2022
2. Omicron BA. 5 neutralization among vaccine-boosted persons with prior Omicron BA. 1/BA. 2 infections;Pedersen;Emerg. Infect. Dis.,2022
3. Early remdesivir to prevent progression to severe Covid-19 in outpatients;Gottlieb;N. Engl. J. Med.,2022
4. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of in vitro antiviral and antimicrobial activities of cepharanthine-luteolin and their interaction with pepsin by multispectral and molecular docking methods;Journal of Molecular Liquids;2024-10
2. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10
3. SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening;SLAS Discovery;2024-09
4. Obesity-compromised immunity in post-COVID-19 condition: a critical control point of chronicity;Frontiers in Immunology;2024-08-12
5. Synthesis, characterization, cytotoxicity, and antiviral activity of new coumarin analogues against coronavirus;Results in Chemistry;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3